We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRND icon
2626
Grindr
GRND
$2.74B
$197K ﹤0.01%
+10,986
New +$193K
MCS icon
2627
Marcus Corp
MCS
$929M
$197K ﹤0.01%
11,781
+909
+8% +$17.6K
PACK icon
2628
Ranpak Holdings
PACK
$479M
$197K ﹤0.01%
36,286
+2,867
+9% +$18.9K
VREX icon
2629
Varex Imaging
VREX
$780M
$197K ﹤0.01%
16,938
+1,527
+10% +$20.2K
STKL
2630
DELISTED
SunOpta
STKL
$196K ﹤0.01%
40,186
+2,305
+6% +$15.3K
MCHB
2631
Mechanics Bancorp
MCHB
$3.79B
$195K ﹤0.01%
16,549
+327
+2% +$3.24K
KALV
2632
DELISTED
KalVista Pharmaceuticals
KALV
$195K ﹤0.01%
16,823
+2,984
+22% +$30.5K
PPTA
2633
Perpetua Resources
PPTA
$3.1B
$195K ﹤0.01%
18,189
+2,467
+16% +$26.5K
SKIN icon
2634
SkinHealth Systems
SKIN
$85.9M
$195K ﹤0.01%
144,797
+30,650
+27% +$46.7K
ARHS icon
2635
Arhaus
ARHS
$1.37B
$194K ﹤0.01%
22,225
+1,761
+9% +$18.8K
EHTH icon
2636
eHealth
EHTH
$38.8M
$194K ﹤0.01%
28,900
+9,500
+49% +$86.4K
NRC icon
2637
NRC Health Common Stock
NRC
$471M
$194K ﹤0.01%
15,115
+865
+6% +$13.9K
SGC icon
2638
Superior Group of Companies
SGC
$210M
$194K ﹤0.01%
17,690
+201
+1% +$2.83K
MED icon
2639
Medifast
MED
$128M
$193K ﹤0.01%
14,273
+2,891
+25% +$43.4K
ALTO icon
2640
Alto Ingredients
ALTO
$326M
$192K ﹤0.01%
168,300
+113,600
+208% +$176K
BLNK icon
2641
Blink Charging
BLNK
$87.1M
$192K ﹤0.01%
208,133
+52,300
+34% +$60.5K
PACS icon
2642
PACS Group
PACS
$7.12B
$192K ﹤0.01%
17,049
+1,525
+10% +$20K
DNTH icon
2643
Dianthus Therapeutics
DNTH
$6.13B
$191K ﹤0.01%
10,491
+1,023
+11% +$22.5K
WEAV icon
2644
Weave Communications
WEAV
$426M
$191K ﹤0.01%
17,213
+1,244
+8% +$17.9K
SENS icon
2645
Senseonics Holdings Inc
SENS
$409M
$190K ﹤0.01%
14,445
ACRS icon
2646
Aclaris Therapeutics
ACRS
$863M
$189K ﹤0.01%
123,100
GPRO icon
2647
GoPro
GPRO
$117M
$189K ﹤0.01%
284,835
CMRE icon
2648
Costamare
CMRE
$1.74B
$188K ﹤0.01%
19,099
+2,000
+12% +$22.1K
FLNC icon
2649
Fluence Energy
FLNC
$2.44B
$188K ﹤0.01%
38,672
+7,297
+23% +$69.8K
LINC icon
2650
Lincoln Educational Services
LINC
$955M
$188K ﹤0.01%
11,793
+1,018
+9% +$16.6K

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.